- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
According to our latest study, the global Somatostatin market size was valued at USD 346.3 million in 2022 and is forecast to a readjusted size of USD 715 million by 2029 with a CAGR of 10.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, followed by Europe and India.
This report is a detailed and comprehensive analysis for global Somatostatin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Somatostatin market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Somatostatin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Somatostatin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Somatostatin market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Somatostatin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Somatostatin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A. and Polypeptide Laboratories, Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Somatostatin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.25mg/pcs
0.75mg/pcs
3mg/pcs
Market segment by Application
Hormonal Disorder
Oncology
Metabolic Disorder
Others
Major players covered
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Somatostatin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Somatostatin, with price, sales, revenue and global market share of Somatostatin from 2018 to 2023.
Chapter 3, the Somatostatin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Somatostatin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Somatostatin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Somatostatin.
Chapter 14 and 15, to describe Somatostatin sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Somatostatin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Somatostatin Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 0.25mg/pcs
1.3.3 0.75mg/pcs
1.3.4 3mg/pcs
1.4 Market Analysis by Application
1.4.1 Overview: Global Somatostatin Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hormonal Disorder
1.4.3 Oncology
1.4.4 Metabolic Disorder
1.4.5 Others
1.5 Global Somatostatin Market Size & Forecast
1.5.1 Global Somatostatin Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Somatostatin Sales Quantity (2018-2029)
1.5.3 Global Somatostatin Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck (Schweiz) AG
2.1.1 Merck (Schweiz) AG Details
2.1.2 Merck (Schweiz) AG Major Business
2.1.3 Merck (Schweiz) AG Somatostatin Product and Services
2.1.4 Merck (Schweiz) AG Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck (Schweiz) AG Recent Developments/Updates
2.2 SANOFI-AVENTIS FRANCE
2.2.1 SANOFI-AVENTIS FRANCE Details
2.2.2 SANOFI-AVENTIS FRANCE Major Business
2.2.3 SANOFI-AVENTIS FRANCE Somatostatin Product and Services
2.2.4 SANOFI-AVENTIS FRANCE Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 SANOFI-AVENTIS FRANCE Recent Developments/Updates
2.3 Lyomark Pharma GmbH
2.3.1 Lyomark Pharma GmbH Details
2.3.2 Lyomark Pharma GmbH Major Business
2.3.3 Lyomark Pharma GmbH Somatostatin Product and Services
2.3.4 Lyomark Pharma GmbH Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Lyomark Pharma GmbH Recent Developments/Updates
2.4 ALFA WASSERMANN S.p.A.
2.4.1 ALFA WASSERMANN S.p.A. Details
2.4.2 ALFA WASSERMANN S.p.A. Major Business
2.4.3 ALFA WASSERMANN S.p.A. Somatostatin Product and Services
2.4.4 ALFA WASSERMANN S.p.A. Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 ALFA WASSERMANN S.p.A. Recent Developments/Updates
2.5 Polypeptide Laboratories, Inc
2.5.1 Polypeptide Laboratories, Inc Details
2.5.2 Polypeptide Laboratories, Inc Major Business
2.5.3 Polypeptide Laboratories, Inc Somatostatin Product and Services
2.5.4 Polypeptide Laboratories, Inc Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Polypeptide Laboratories, Inc Recent Developments/Updates
2.6 SAMARTH
2.6.1 SAMARTH Details
2.6.2 SAMARTH Major Business
2.6.3 SAMARTH Somatostatin Product and Services
2.6.4 SAMARTH Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SAMARTH Recent Developments/Updates
2.7 UBPL
2.7.1 UBPL Details
2.7.2 UBPL Major Business
2.7.3 UBPL Somatostatin Product and Services
2.7.4 UBPL Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 UBPL Recent Developments/Updates
2.8 HYBIO
2.8.1 HYBIO Details
2.8.2 HYBIO Major Business
2.8.3 HYBIO Somatostatin Product and Services
2.8.4 HYBIO Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 HYBIO Recent Developments/Updates
2.9 TianTaiShan
2.9.1 TianTaiShan Details
2.9.2 TianTaiShan Major Business
2.9.3 TianTaiShan Somatostatin Product and Services
2.9.4 TianTaiShan Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 TianTaiShan Recent Developments/Updates
2.10 Yangtze River
2.10.1 Yangtze River Details
2.10.2 Yangtze River Major Business
2.10.3 Yangtze River Somatostatin Product and Services
2.10.4 Yangtze River Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Yangtze River Recent Developments/Updates
2.11 Siyao
2.11.1 Siyao Details
2.11.2 Siyao Major Business
2.11.3 Siyao Somatostatin Product and Services
2.11.4 Siyao Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Siyao Recent Developments/Updates
2.12 Shuangcheng
2.12.1 Shuangcheng Details
2.12.2 Shuangcheng Major Business
2.12.3 Shuangcheng Somatostatin Product and Services
2.12.4 Shuangcheng Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shuangcheng Recent Developments/Updates
2.13 Hainan Zhonghe
2.13.1 Hainan Zhonghe Details
2.13.2 Hainan Zhonghe Major Business
2.13.3 Hainan Zhonghe Somatostatin Product and Services
2.13.4 Hainan Zhonghe Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hainan Zhonghe Recent Developments/Updates
2.14 SL PHARM
2.14.1 SL PHARM Details
2.14.2 SL PHARM Major Business
2.14.3 SL PHARM Somatostatin Product and Services
2.14.4 SL PHARM Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 SL PHARM Recent Developments/Updates
2.15 Wuhan Hualong
2.15.1 Wuhan Hualong Details
2.15.2 Wuhan Hualong Major Business
2.15.3 Wuhan Hualong Somatostatin Product and Services
2.15.4 Wuhan Hualong Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Wuhan Hualong Recent Developments/Updates
2.16 Qingdao Guoda
2.16.1 Qingdao Guoda Details
2.16.2 Qingdao Guoda Major Business
2.16.3 Qingdao Guoda Somatostatin Product and Services
2.16.4 Qingdao Guoda Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Qingdao Guoda Recent Developments/Updates
2.17 Chengdu Shengnuo
2.17.1 Chengdu Shengnuo Details
2.17.2 Chengdu Shengnuo Major Business
2.17.3 Chengdu Shengnuo Somatostatin Product and Services
2.17.4 Chengdu Shengnuo Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Chengdu Shengnuo Recent Developments/Updates
2.18 Longjin
2.18.1 Longjin Details
2.18.2 Longjin Major Business
2.18.3 Longjin Somatostatin Product and Services
2.18.4 Longjin Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Longjin Recent Developments/Updates
3 Competitive Environment: Somatostatin by Manufacturer
3.1 Global Somatostatin Sales Quantity by Manufacturer (2018-2023)
3.2 Global Somatostatin Revenue by Manufacturer (2018-2023)
3.3 Global Somatostatin Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Somatostatin by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Somatostatin Manufacturer Market Share in 2022
3.4.2 Top 6 Somatostatin Manufacturer Market Share in 2022
3.5 Somatostatin Market: Overall Company Footprint Analysis
3.5.1 Somatostatin Market: Region Footprint
3.5.2 Somatostatin Market: Company Product Type Footprint
3.5.3 Somatostatin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Somatostatin Market Size by Region
4.1.1 Global Somatostatin Sales Quantity by Region (2018-2029)
4.1.2 Global Somatostatin Consumption Value by Region (2018-2029)
4.1.3 Global Somatostatin Average Price by Region (2018-2029)
4.2 North America Somatostatin Consumption Value (2018-2029)
4.3 Europe Somatostatin Consumption Value (2018-2029)
4.4 Asia-Pacific Somatostatin Consumption Value (2018-2029)
4.5 South America Somatostatin Consumption Value (2018-2029)
4.6 Middle East and Africa Somatostatin Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Somatostatin Sales Quantity by Type (2018-2029)
5.2 Global Somatostatin Consumption Value by Type (2018-2029)
5.3 Global Somatostatin Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Somatostatin Sales Quantity by Application (2018-2029)
6.2 Global Somatostatin Consumption Value by Application (2018-2029)
6.3 Global Somatostatin Average Price by Application (2018-2029)
7 North America
7.1 North America Somatostatin Sales Quantity by Type (2018-2029)
7.2 North America Somatostatin Sales Quantity by Application (2018-2029)
7.3 North America Somatostatin Market Size by Country
7.3.1 North America Somatostatin Sales Quantity by Country (2018-2029)
7.3.2 North America Somatostatin Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Somatostatin Sales Quantity by Type (2018-2029)
8.2 Europe Somatostatin Sales Quantity by Application (2018-2029)
8.3 Europe Somatostatin Market Size by Country
8.3.1 Europe Somatostatin Sales Quantity by Country (2018-2029)
8.3.2 Europe Somatostatin Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Somatostatin Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Somatostatin Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Somatostatin Market Size by Region
9.3.1 Asia-Pacific Somatostatin Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Somatostatin Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Somatostatin Sales Quantity by Type (2018-2029)
10.2 South America Somatostatin Sales Quantity by Application (2018-2029)
10.3 South America Somatostatin Market Size by Country
10.3.1 South America Somatostatin Sales Quantity by Country (2018-2029)
10.3.2 South America Somatostatin Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Somatostatin Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Somatostatin Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Somatostatin Market Size by Country
11.3.1 Middle East & Africa Somatostatin Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Somatostatin Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Somatostatin Market Drivers
12.2 Somatostatin Market Restraints
12.3 Somatostatin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Somatostatin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Somatostatin
13.3 Somatostatin Production Process
13.4 Somatostatin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Somatostatin Typical Distributors
14.3 Somatostatin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Somatostatin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Somatostatin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck (Schweiz) AG Basic Information, Manufacturing Base and Competitors
Table 4. Merck (Schweiz) AG Major Business
Table 5. Merck (Schweiz) AG Somatostatin Product and Services
Table 6. Merck (Schweiz) AG Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck (Schweiz) AG Recent Developments/Updates
Table 8. SANOFI-AVENTIS FRANCE Basic Information, Manufacturing Base and Competitors
Table 9. SANOFI-AVENTIS FRANCE Major Business
Table 10. SANOFI-AVENTIS FRANCE Somatostatin Product and Services
Table 11. SANOFI-AVENTIS FRANCE Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. SANOFI-AVENTIS FRANCE Recent Developments/Updates
Table 13. Lyomark Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 14. Lyomark Pharma GmbH Major Business
Table 15. Lyomark Pharma GmbH Somatostatin Product and Services
Table 16. Lyomark Pharma GmbH Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Lyomark Pharma GmbH Recent Developments/Updates
Table 18. ALFA WASSERMANN S.p.A. Basic Information, Manufacturing Base and Competitors
Table 19. ALFA WASSERMANN S.p.A. Major Business
Table 20. ALFA WASSERMANN S.p.A. Somatostatin Product and Services
Table 21. ALFA WASSERMANN S.p.A. Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. ALFA WASSERMANN S.p.A. Recent Developments/Updates
Table 23. Polypeptide Laboratories, Inc Basic Information, Manufacturing Base and Competitors
Table 24. Polypeptide Laboratories, Inc Major Business
Table 25. Polypeptide Laboratories, Inc Somatostatin Product and Services
Table 26. Polypeptide Laboratories, Inc Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Polypeptide Laboratories, Inc Recent Developments/Updates
Table 28. SAMARTH Basic Information, Manufacturing Base and Competitors
Table 29. SAMARTH Major Business
Table 30. SAMARTH Somatostatin Product and Services
Table 31. SAMARTH Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. SAMARTH Recent Developments/Updates
Table 33. UBPL Basic Information, Manufacturing Base and Competitors
Table 34. UBPL Major Business
Table 35. UBPL Somatostatin Product and Services
Table 36. UBPL Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. UBPL Recent Developments/Updates
Table 38. HYBIO Basic Information, Manufacturing Base and Competitors
Table 39. HYBIO Major Business
Table 40. HYBIO Somatostatin Product and Services
Table 41. HYBIO Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. HYBIO Recent Developments/Updates
Table 43. TianTaiShan Basic Information, Manufacturing Base and Competitors
Table 44. TianTaiShan Major Business
Table 45. TianTaiShan Somatostatin Product and Services
Table 46. TianTaiShan Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. TianTaiShan Recent Developments/Updates
Table 48. Yangtze River Basic Information, Manufacturing Base and Competitors
Table 49. Yangtze River Major Business
Table 50. Yangtze River Somatostatin Product and Services
Table 51. Yangtze River Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Yangtze River Recent Developments/Updates
Table 53. Siyao Basic Information, Manufacturing Base and Competitors
Table 54. Siyao Major Business
Table 55. Siyao Somatostatin Product and Services
Table 56. Siyao Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Siyao Recent Developments/Updates
Table 58. Shuangcheng Basic Information, Manufacturing Base and Competitors
Table 59. Shuangcheng Major Business
Table 60. Shuangcheng Somatostatin Product and Services
Table 61. Shuangcheng Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Shuangcheng Recent Developments/Updates
Table 63. Hainan Zhonghe Basic Information, Manufacturing Base and Competitors
Table 64. Hainan Zhonghe Major Business
Table 65. Hainan Zhonghe Somatostatin Product and Services
Table 66. Hainan Zhonghe Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Hainan Zhonghe Recent Developments/Updates
Table 68. SL PHARM Basic Information, Manufacturing Base and Competitors
Table 69. SL PHARM Major Business
Table 70. SL PHARM Somatostatin Product and Services
Table 71. SL PHARM Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. SL PHARM Recent Developments/Updates
Table 73. Wuhan Hualong Basic Information, Manufacturing Base and Competitors
Table 74. Wuhan Hualong Major Business
Table 75. Wuhan Hualong Somatostatin Product and Services
Table 76. Wuhan Hualong Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Wuhan Hualong Recent Developments/Updates
Table 78. Qingdao Guoda Basic Information, Manufacturing Base and Competitors
Table 79. Qingdao Guoda Major Business
Table 80. Qingdao Guoda Somatostatin Product and Services
Table 81. Qingdao Guoda Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Qingdao Guoda Recent Developments/Updates
Table 83. Chengdu Shengnuo Basic Information, Manufacturing Base and Competitors
Table 84. Chengdu Shengnuo Major Business
Table 85. Chengdu Shengnuo Somatostatin Product and Services
Table 86. Chengdu Shengnuo Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Chengdu Shengnuo Recent Developments/Updates
Table 88. Longjin Basic Information, Manufacturing Base and Competitors
Table 89. Longjin Major Business
Table 90. Longjin Somatostatin Product and Services
Table 91. Longjin Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Longjin Recent Developments/Updates
Table 93. Global Somatostatin Sales Quantity by Manufacturer (2018-2023) & (K Pcs)
Table 94. Global Somatostatin Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Somatostatin Average Price by Manufacturer (2018-2023) & (USD/Pcs)
Table 96. Market Position of Manufacturers in Somatostatin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Somatostatin Production Site of Key Manufacturer
Table 98. Somatostatin Market: Company Product Type Footprint
Table 99. Somatostatin Market: Company Product Application Footprint
Table 100. Somatostatin New Market Entrants and Barriers to Market Entry
Table 101. Somatostatin Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Somatostatin Sales Quantity by Region (2018-2023) & (K Pcs)
Table 103. Global Somatostatin Sales Quantity by Region (2024-2029) & (K Pcs)
Table 104. Global Somatostatin Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Somatostatin Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Somatostatin Average Price by Region (2018-2023) & (USD/Pcs)
Table 107. Global Somatostatin Average Price by Region (2024-2029) & (USD/Pcs)
Table 108. Global Somatostatin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 109. Global Somatostatin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 110. Global Somatostatin Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Somatostatin Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Somatostatin Average Price by Type (2018-2023) & (USD/Pcs)
Table 113. Global Somatostatin Average Price by Type (2024-2029) & (USD/Pcs)
Table 114. Global Somatostatin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 115. Global Somatostatin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 116. Global Somatostatin Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Somatostatin Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Somatostatin Average Price by Application (2018-2023) & (USD/Pcs)
Table 119. Global Somatostatin Average Price by Application (2024-2029) & (USD/Pcs)
Table 120. North America Somatostatin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 121. North America Somatostatin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 122. North America Somatostatin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 123. North America Somatostatin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 124. North America Somatostatin Sales Quantity by Country (2018-2023) & (K Pcs)
Table 125. North America Somatostatin Sales Quantity by Country (2024-2029) & (K Pcs)
Table 126. North America Somatostatin Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Somatostatin Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Somatostatin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 129. Europe Somatostatin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 130. Europe Somatostatin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 131. Europe Somatostatin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 132. Europe Somatostatin Sales Quantity by Country (2018-2023) & (K Pcs)
Table 133. Europe Somatostatin Sales Quantity by Country (2024-2029) & (K Pcs)
Table 134. Europe Somatostatin Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Somatostatin Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Somatostatin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 137. Asia-Pacific Somatostatin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 138. Asia-Pacific Somatostatin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 139. Asia-Pacific Somatostatin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 140. Asia-Pacific Somatostatin Sales Quantity by Region (2018-2023) & (K Pcs)
Table 141. Asia-Pacific Somatostatin Sales Quantity by Region (2024-2029) & (K Pcs)
Table 142. Asia-Pacific Somatostatin Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Somatostatin Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Somatostatin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 145. South America Somatostatin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 146. South America Somatostatin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 147. South America Somatostatin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 148. South America Somatostatin Sales Quantity by Country (2018-2023) & (K Pcs)
Table 149. South America Somatostatin Sales Quantity by Country (2024-2029) & (K Pcs)
Table 150. South America Somatostatin Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Somatostatin Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Somatostatin Sales Quantity by Type (2018-2023) & (K Pcs)
Table 153. Middle East & Africa Somatostatin Sales Quantity by Type (2024-2029) & (K Pcs)
Table 154. Middle East & Africa Somatostatin Sales Quantity by Application (2018-2023) & (K Pcs)
Table 155. Middle East & Africa Somatostatin Sales Quantity by Application (2024-2029) & (K Pcs)
Table 156. Middle East & Africa Somatostatin Sales Quantity by Region (2018-2023) & (K Pcs)
Table 157. Middle East & Africa Somatostatin Sales Quantity by Region (2024-2029) & (K Pcs)
Table 158. Middle East & Africa Somatostatin Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Somatostatin Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Somatostatin Raw Material
Table 161. Key Manufacturers of Somatostatin Raw Materials
Table 162. Somatostatin Typical Distributors
Table 163. Somatostatin Typical Customers
List of Figures
Figure 1. Somatostatin Picture
Figure 2. Global Somatostatin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Somatostatin Consumption Value Market Share by Type in 2022
Figure 4. 0.25mg/pcs Examples
Figure 5. 0.75mg/pcs Examples
Figure 6. 3mg/pcs Examples
Figure 7. Global Somatostatin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Somatostatin Consumption Value Market Share by Application in 2022
Figure 9. Hormonal Disorder Examples
Figure 10. Oncology Examples
Figure 11. Metabolic Disorder Examples
Figure 12. Others Examples
Figure 13. Global Somatostatin Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Somatostatin Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Somatostatin Sales Quantity (2018-2029) & (K Pcs)
Figure 16. Global Somatostatin Average Price (2018-2029) & (USD/Pcs)
Figure 17. Global Somatostatin Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Somatostatin Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Somatostatin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Somatostatin Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Somatostatin Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Somatostatin Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Somatostatin Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Somatostatin Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Somatostatin Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Somatostatin Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Somatostatin Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Somatostatin Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Somatostatin Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Somatostatin Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Somatostatin Average Price by Type (2018-2029) & (USD/Pcs)
Figure 32. Global Somatostatin Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Somatostatin Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Somatostatin Average Price by Application (2018-2029) & (USD/Pcs)
Figure 35. North America Somatostatin Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Somatostatin Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Somatostatin Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Somatostatin Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Somatostatin Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Somatostatin Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Somatostatin Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Somatostatin Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Somatostatin Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Somatostatin Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Somatostatin Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Somatostatin Consumption Value Market Share by Region (2018-2029)
Figure 55. China Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Somatostatin Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Somatostatin Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Somatostatin Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Somatostatin Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Somatostatin Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Somatostatin Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Somatostatin Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Somatostatin Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Somatostatin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Somatostatin Market Drivers
Figure 76. Somatostatin Market Restraints
Figure 77. Somatostatin Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Somatostatin in 2022
Figure 80. Manufacturing Process Analysis of Somatostatin
Figure 81. Somatostatin Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
